All In Biotech

Free tool

FAERS Monitor: Infuvite Pediatric (Pharmacy Bulk Package)

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021265 or its brand name (Infuvite Pediatric (Pharmacy Bulk Package), Ascorbic Acid, Biotin, Cholecalciferol, Cyanocobalamin, Dexpanthenol, Folic Acid, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol Acetate, Vitamin A, Vitamin K). Reports on generic versions are filed under their own applications.

Reports

24

Serious

14

58% of reports

Hospitalization

2

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea4
  • cough3
  • erythema3
  • rash generalised3
  • tachycardia3
  • vomiting3
  • anaphylactic reaction2
  • chest discomfort2
  • grunting2
  • hypersensitivity2
  • medication error2
  • paraesthesia2
  • product dispensing error2
  • rash2
  • rash erythematous2

Reports by year received

View as table
YearReports
20043
20091
20111
20122
20141
20165
20181
20191
20201
20215
20221
20241
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,135 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
grunting22938.9777.83,292
rash generalisedSignal3101.635.2207
product dispensing error280.521.488
rash erythematous236.79.738
anaphylactic reaction231.78.433
medication error231.58.433
tachycardiaSignal329.610.357
chest discomfort217.14.516
erythemaSignal312.84.422
paraesthesia211.13.010
hypersensitivity29.42.58
coughSignal39.43.315
dyspnoeaSignal46.22.513
vomitingSignal35.61.97
rash24.01.12

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.